FundedIQ
Biotechnology

KetoSwiss: Funding, Investors & Team (Sep 2026)

KetoSwiss, a BioTech startup from Switzerland, aims to reintroduce ketone bodies to combat diseases in the modern world. The company focuses on creating and evaluating a unique nutraceutical/medical food for the dietary preventive treatment of migraines with high frequency and potentially other neurological disorders caused by metabolic dysfunction, like Alzheimer's disease. KetoSwiss is located in the Technologie Park Basel in Basel, Switzerland, which is a vibrant hub of scientific research, entrepreneurial activities, and pioneering biotech startups.

www.keto.swiss LinkedIn Basel, Switzerland 1-10 employees
Total raised
$4.8M
Rounds
2
Latest
Seed
Aug 2023

KetoSwiss has raised $4.8M across 2 funding rounds on record, the most recent a Seed of $800k announced in Aug 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

KetoSwiss Company Profile and Key Stats

Total funding raised
$4.8M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$800k in Aug 2023
Employees
1-10
reported band
Headquarters
Basel, Switzerland

Latest funding round on record: Aug 2023.

KetoSwiss Funding Rounds

Date
Round
Amount
Seed
$800k
Seed
$4.0M

KetoSwiss raised $4.0M in a Seed announced in Oct 2022.

10 months later, a Seed of $800k was announced in Aug 2023.

KetoSwiss Founders and Leadership Team

Name
Role
Contact
Dr Elena Gross
CEO

No contact details are on record for this team yet.

KetoSwiss Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
879
$3.8M
16,485
$3.1M

KetoSwiss' latest round of $800k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like KetoSwiss in Biotechnology and Basel

Companies Similar to KetoSwiss

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…

Pre-Seed $3.0M

compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…

Undisclosed round $1.2M

MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…

Undisclosed round $200M

Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…

Undisclosed round $490k

Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…

Pre-Seed $120k

Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…

Undisclosed round $1.1M

AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…

Undisclosed round $4.0M

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…

Undisclosed round $1.2M

Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…

Undisclosed round $1.4M

MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…

Undisclosed round $10.2M

Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…

Seed $7.5M

KetoSwiss Funding FAQs

What does KetoSwiss do?

KetoSwiss, a BioTech startup from Switzerland, aims to reintroduce ketone bodies to combat diseases in the modern world. The company focuses on creating and evaluating a unique nutraceutical/medical food for the dietary preventive treatment of migraines with high frequency and potentially other neurological disorders caused by metabolic dysfunction, like Alzheimer's disease. KetoSwiss is located in the Technologie Park Basel in Basel, Switzerland, which is a vibrant hub of scientific research, entrepreneurial activities, and pioneering biotech startups.

How much funding has KetoSwiss raised?

KetoSwiss has raised $4.8M across 2 rounds on record. The most recent is a Seed of $800k announced in Aug 2023.

When did KetoSwiss last raise funding?

KetoSwiss' most recent funding round on record is a Seed of $800k, announced in Aug 2023.

Who is the CEO of KetoSwiss?

Dr Elena Gross is listed as CEO at KetoSwiss.

Where is KetoSwiss headquartered?

KetoSwiss is based in Basel, Basel-Stadt, Switzerland.

How many employees does KetoSwiss have?

KetoSwiss is in the 1-10 employee band.

How does KetoSwiss' funding compare to other Biotechnology startups?

KetoSwiss' latest round of $800k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's KetoSwiss Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KetoSwiss is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.